Valeant Pharmaceuticals (VRX): Bill Ackman’s Pershing Square Lands Board Seat

Page 4 of 7 SEC Filing

---

13D

CUSIP No. 91911K102		Page 4

1		Name of reporting person William A. Ackman
2		Check the appropriate box if a member of a group (see instructions) (a)  ¨        (b)  ¨
3		SEC use only
4		Source of funds (see instructions) OO (See Item 3)
5		Check box if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e) ¨
6		Citizenship or place of organization United States
Number of shares beneficially owned by each reporting person with				7		Sole voting power 0
				8		Shared voting power 30,711,122
				9		Sole dispositive power 0
				10		Shared dispositive power 30,711,122
11		Aggregate amount beneficially owned by each reporting person 30,711,122
12		Check box if the aggregate amount in Row (11) excludes certain shares ¨
13		Percent of class represented by amount in Row (11) 9.0%(3)
14		Type of reporting person IN

(3)	Calculated based on 343,101,797 shares of common stock, no par value, of Valeant Pharmaceuticals International, Inc. outstanding as of October 19, 2015, as reported on Valeant Pharmaceuticals International, Inc.s quarterly report filed on Form 10-Q on October 26, 2015.

Follow Bausch Health Companies Inc. (NYSE:BHC)

Follow Bausch Health Companies Inc. (NYSE:BHC)

---

or

Subscribe with Google

We may use your email to send marketing emails about our services. Click here to read our privacy policy.